Quarterly report · Q2
4937.TEDINET S100QQ4K
Period2022-10-01 → 2023-03-31
Filed2023-05-12
StandardJapan GAAP
ConsolidatedYes
Data checks11 of 11 passed
Key figures · 43
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥900m | 2022-10-01 → 2023-03-31 | Cons. | Net sales |
| Revenue | ¥2.7bn | 2021-10-01 → 2022-09-30 | Cons. | Net sales (5-year summary) |
| Operating income | ¥209m | 2022-10-01 → 2023-03-31 | Cons. | Operating income |
| Ordinary income | ¥216m | 2022-10-01 → 2023-03-31 | Cons. | Ordinary income |
| Ordinary income | −¥22m | 2021-10-01 → 2022-09-30 | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥216m | 2022-10-01 → 2023-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥211m | 2022-10-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥57m | 2021-10-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥211m | 2022-10-01 → 2023-03-31 | Cons. | Profit loss |
| Total assets | ¥1.6bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥1.6bn | at 2022-09-30 | Cons. | Assets |
| Total liabilities | ¥677m | at 2023-03-31 | Cons. | Liabilities |
| Total liabilities | ¥821m | at 2022-09-30 | Cons. | Liabilities |
| Net assets / equity | ¥954m | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥743m | at 2022-09-30 | Cons. | Net assets |
| Cash and deposits | ¥1.2bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥906m | at 2022-09-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥1.2bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥906m | at 2022-09-30 | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥365m | 2022-10-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥169m | 2021-10-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | ¥9m | 2022-10-01 → 2023-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥176m | 2021-10-01 → 2022-09-30 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥107m | 2022-10-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥129m | 2021-10-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥70.24 | 2022-10-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥47.62 | 2023-01-01 → 2023-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-19.04 | 2021-10-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥69.52 | 2022-10-01 → 2023-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 58.5% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 47.5% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Revenue | ¥1.4bn | 2021-10-01 → 2022-03-31 | Standalone | Net sales (5-year summary) |
| Ordinary income | −¥33m | 2021-10-01 → 2022-03-31 | Standalone | Ordinary income loss (5-year summary) |
| Net income | −¥38m | 2021-10-01 → 2022-03-31 | Standalone | Net income loss (5-year summary) |
| Total assets | ¥1.8bn | at 2022-03-31 | Standalone | Total assets (5-year summary) |
| Net assets / equity | ¥759m | at 2022-03-31 | Standalone | Net assets (5-year summary) |
| Cash & equivalents | ¥1.0bn | at 2022-03-31 | Standalone | Cash and cash equivalents (5-year summary) |
| Operating cash flow | −¥3m | 2021-10-01 → 2022-03-31 | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | ¥6m | 2021-10-01 → 2022-03-31 | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥20m | 2021-10-01 → 2022-03-31 | Standalone | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥-12.73 | 2021-10-01 → 2022-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥5.05 | 2022-01-01 → 2022-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| Equity ratio | 43.3% | at 2022-03-31 | Standalone | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 12
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | segment profit | 2022-10-01 → 2023-03-31 | −¥188m |
| jpcrp040300-q2r_E36697-000Direct To Consumer Businessreportable segment | revenue | 2022-10-01 → 2023-03-31 | ¥859m |
| jpcrp040300-q2r_E36697-000Direct To Consumer Businessreportable segment | revenue external | 2022-10-01 → 2023-03-31 | ¥860m |
| jpcrp040300-q2r_E36697-000Direct To Consumer Businessreportable segment | revenue intersegment | 2022-10-01 → 2023-03-31 | −¥386,000 |
| jpcrp040300-q2r_E36697-000Direct To Consumer Businessreportable segment | segment profit | 2022-10-01 → 2023-03-31 | ¥399m |
| jpcrp040300-q2r_E36697-000Medical Supportreportable segment | revenue | 2022-10-01 → 2023-03-31 | ¥41m |
| jpcrp040300-q2r_E36697-000Medical Supportreportable segment | revenue external | 2022-10-01 → 2023-03-31 | ¥41m |
| jpcrp040300-q2r_E36697-000Medical Supportreportable segment | segment profit | 2022-10-01 → 2023-03-31 | −¥2m |
| —segment total | revenue | 2022-10-01 → 2023-03-31 | ¥900m |
| —segment total | revenue external | 2022-10-01 → 2023-03-31 | ¥901m |
| —segment total | revenue intersegment | 2022-10-01 → 2023-03-31 | −¥386,000 |
| —segment total | segment profit | 2022-10-01 → 2023-03-31 | ¥397m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 317
| Item | Context | Value | Unit |
|---|---|---|---|
| Quarterly consolidated balance sheet (text) | CurrentYTDDuration | Text · Plus | |
| Year to quarter end consolidated statement of income (text) | CurrentYTDDuration | Text · Plus | |
| Year to quarter end consolidated statement of comprehensive income (text) | CurrentYTDDuration | Text · Plus | |
| Quarterly consolidated statement of cash flows (text) | CurrentYTDDuration | Text · Plus | |
| Notes changes in accounting policies in accordance with changes in accounting standards etc quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes additional information quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Major components of selling general and administrative expenses (text) | CurrentYTDDuration | Text · Plus | |
| Reconciliation of ending balance of cash and cash equivalents with account balances per balance sheet (text) | CurrentYTDDuration | Text · Plus | |
| Notes regarding dividend (text) | CurrentYTDDuration | Text · Plus | |
| Notes when there is significant changes in amounts of equity (text) | CurrentYTDDuration | Text · Plus | |
| Notes segment information etc quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Footnotes regarding segment information table (text) | CurrentYTDDuration | Text · Plus | |
| Notes revenue recognition quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes per share information quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Notes significant events after reporting period quarterly consolidated financial statements (text) | CurrentYTDDuration | Text · Plus | |
| Other information consolidated financial statements etc (text) | CurrentYTDDuration | Text · Plus | |
| Information about company which provides guarantee to reporting company (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 11 of 11 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |